The Journal of Pediatrics
Volume 152, Issue 6 , Pages 750-752 , June 2008

Metformin as a Weight-Loss Tool in “At-Risk” Obese Adolescents: A Magic Bullet?

  • Josephine Z. Kasa-Vubu, MD, MS

      Affiliations

    • Corresponding Author InformationReprint requests: Josephine Z. Kasa-Vubu, MD, MS, Department of Pediatrics, Endocrine Division, University of Michigan Medical Center, Ann Arbor, MI 48019-0718.

References 

  1. Metzger BE. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol. 2007;50:972–979
  2. Bouhours-Nouet N, Dufresne S, de Casson FB, Mathieu E, Douay O, Gatelais F, et al. High birth weight and early postnatal weight gain protect obese children and adolescents from truncal adiposity and insulin resistance: metabolically healthy but obese subjects?. Diabetes Care. 2008;In press
  3. Watkins MG, Clark KM, Foster CM, Welch KB, Kasa-Vubu JZ. Relationships among body mass index, parental perceptions, birthweight and parental weight after referral to a weight clinic. J Natl Med Assoc. 2007;99:908–913
  4. de Zegher F, Ibanez L. Prenatal growth restraint followed by catch-up of weight: a hyperinsulinemic pathway to polycystic ovary syndrome. Fertil Steril. 2006;86(Suppl 1):S4–S5
  5. Vuguin P, Grinstein G, Freeman K, Saenger P, DiMartino Nardi J. Prediction models for insulin resistance in girls with premature adrenarche (The premature adrenarche insulin resistance score: PAIR score). Horm Res. 2006;65:185–191
  6. Lumeng JC, Appugliese D, Cabral HJ, Bradley RH, Zuckerman B. Neighborhood safety and overweight status in children. Arch Pediatr Adolesc Med. 2006;160:25–31
  7. Sallis JF, Glanz K. The role of built environments in physical activity, eating, and obesity in childhood. Future Child. 2006;16:89–108
  8. Taylor RW, McAuley KA, Williams SM, Barbezat W, Nielsen G, Mann JI. Reducing weight gain in children through enhancing physical activity and nutrition: the APPLE project. Int J Pediatr Obes. 2006;1:146–152
  9. Levine JA. Nonexercise activity thermogenesis—liberating the life-force. J Intern Med. 2007;262:273–287
  10. Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care. 2005;28:186–212
  11. Kasa-Vubu JZ, Lee CC, Rosenthal A, Singer K, Halter JB. Cardiovascular fitness and exercise as determinants of insulin resistance in postpubertal adolescent females. J Clin Endocrinol Metab. 2005;90:849–854Epub 2004 Nov 30
  12. Maffeis C, Banzato C, Talamini G. Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr. 2008;152:207–213
  13. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care. 1992;15:815–819
  14. Saad R, Gungor N, Arslanian S. Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates. Pediatr Diabetes. 2005;6:95–99
  15. Nguyen S, McCulloch C, Brakeman P, Portale A, Hsu CY. Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics. 2008;121:37–45
  16. Kahn R. Metabolic syndrome: is it a syndrome? (Does it matter?). Circulation. 2007;115:1806–1811
  17. Goodman E, Daniels SR, Meigs JB, Dolan LM. Instability in the diagnosis of metabolic syndrome in adolescents. Circulation. 2007;115:2316–2322
  18. Yamada S, Tsukamoto Y, Irie J. Waist circumference in metabolic syndrome. Lancet. 2007;370:1541–1542
  19. Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents. Lancet. 2007;369:2059–2061
  20. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005;28:902–909
  21. Gahagan S, Silverstein J. Prevention and treatment of type 2 diabetes mellitus in children, with special emphasis on American Indian and Alaska Native children (American Academy of Pediatrics Committee on Native American Child Health). Pediatrics. 2003;112:e328
  22. Goran MI, Ball GD, Cruz ML. Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab. 2003;88:1417–1427
  23. EndocrineSciences aEC (Expected values and S.I unit conversion tables). 3rd ed.. California: Las Calabasa; 2003;
  24. Kruger J, Galuska DA, Serdula MK, Jones DA. Attempting to lose weight: specific practices among US adults. Am J Prev Med. 2004;26:402–406
  25. Ratner RE. An update on the Diabetes Prevention Program. Endocr Pract. 2006;12(Suppl 1):20–24
  26. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289–297
  27. Love-Osborne K, Sheeder J, Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr. 2008;152:817–822
  28. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549–1555
  29. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22:141–146
  30. McCartney CR, Prendergast KA, Chhabra S, Eagleson CA, Yoo R, Chang RJ, et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J Clin Endocrinol Metab. 2006;91:1714–1722Epub 2006 Feb 21
  31. Arslanian SA, Lewy V, Danadian K, Saad R. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab. 2002;87:1555–1559
  32. Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril. 2004;82:421–429
  33. Kumanyika SK. Special issues regarding obesity in minority populations. Ann Intern Med. 1993;119:650–654

PII: S0022-3476(08)00198-4

doi: 10.1016/j.jpeds.2008.03.006

The Journal of Pediatrics
Volume 152, Issue 6 , Pages 750-752 , June 2008

Article Tools